Advanced search
Publication Cover
Infection and Drug Resistance Volume 15, 2022 - Issue
Submit an article Journal homepage
139
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Identification of NS5B Resistance-Associated Mutations in Hepatitis C Virus Circulating in Treatment Naïve Vietnamese Patients

Thu Kim Nguyen1 Clinical Laboratories, National Hospital for Tropical Diseases, Hanoi, Vietnam;2 Infectious Department, Hanoi Medical University, Hanoi, VietnamORCID Iconhttps://orcid.org/0000-0002-0858-2688
ORCID Icon &
Duyet Van Le1 Clinical Laboratories, National Hospital for Tropical Diseases, Hanoi, VietnamCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0389-6514
ORCID Icon
Pages 1547-1554 | Published online: 05 Apr 2022

References

  • Huy Do S. Epidemiology of hepatitis B and C virus infections and liver cancer in Vietnam. Euroas J Hepatogastroenterol. 2015;5(1):49–51. doi:10.5005/jp-journals-10018-1130
  • Nakata S, Song P, Duc DD, et al. Hepatitis C and B virus infections in populations at low or high risk in Ho Chi Minh and Hanoi, Vietnam. J Gastroenterol Hepatol. 1994;9(4):416–419. doi:10.1111/j.1440-1746.1994.tb01265.x
  • Leone N, Rizzetto M. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma. Minerva Gastroenterol Dietol. 2005;51(1):31–46.
  • Wirth TC, Manns MP. The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma. Ann Oncol. 2016;27(8):1467–1474. doi:10.1093/annonc/mdw219
  • El-Shamy A, Hotta H. Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview. World J Gastroenterol. 2014;20(24):7555–7569. doi:10.3748/wjg.v20.i24.7555
  • Sorbo MC, Cento V, Di Maio VC, et al. Hepatitis C virus drug resistance associated substitutions and their clinical relevance: update 2018. Drug Resist Updat. 2018;37:17–39. doi:10.1016/j.drup.2018.01.004
  • Powdrill MH, Bernatchez JA, Gotte M. Inhibitors of the hepatitis C virus RNA-dependent RNA polymerase NS5B. Viruses. 2010;2(10):2169–2195. doi:10.3390/v2102169
  • Rolland S, Vachon ML. Sofosbuvir for the treatment of hepatitis C virus infection. CMAJ. 2015;187(3):203–204. doi:10.1503/cmaj.140151
  • Khaliq S, Raza SM. Current status of direct acting antiviral agents against hepatitis C virus infection in Pakistan. Medicina. 2018;54(5). doi:10.3390/medicina54050080
  • Halfon P, Locarnini S. Hepatitis C virus resistance to protease inhibitors. J Hepatol. 2011;55(1):192–206. doi:10.1016/j.jhep.2011.01.011
  • Yang S, Xing H, Feng S, et al. Prevalence of NS5B resistance-associated variants in treatment-naive Asian patients with chronic hepatitis C. Arch Virol. 2018;163(2):467–473. doi:10.1007/s00705-017-3640-6
  • Bertoli A, Sorbo MC, Aragri M, et al. Prevalence of single and multiple natural NS3, NS5A and NS5B resistance-associated substitutions in hepatitis C virus genotypes 1–4 in Italy. Sci Rep. 2018;8(1):8988. doi:10.1038/s41598-018-26862-y
  • Raj VS, Hundie GB, Schurch AC, et al. Identification of HCV resistant variants against direct acting antivirals in plasma and liver of treatment naive patients. Sci Rep. 2017;7(1):4688. doi:10.1038/s41598-017-04931-y
  • Ruiz-Jarabo CM, Arias A, Baranowski E, Escarmis C, Domingo E. Memory in viral quasispecies. J Virol. 2000;74(8):3543–3547. doi:10.1128/JVI.74.8.3543-3547.2000
  • Castilho MC, Martins AN, Horbach IS, et al. Association of hepatitis C virus NS5B variants with resistance to new antiviral drugs among untreated patients. Mem Inst Oswaldo Cruz. 2011;106(8):968–975. doi:10.1590/S0074-02762011000800011

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.